Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Idorsia Pharmaceutical Ltd patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US20230391757A1 | Application | Crystalline forms of a 4-pyrimidinesulfamide derivative aprocitentan | A61K31/4035; A61K31/41; A61K31/4418; A61K31/506; A61K31/549; A61P13/12; A61P9/12; C07B2200/13; C07D403/12 | December 07, 2023 |
| EP4284508A1 | Application | Kristalline form eines piperazinylthiazolderivats | A61P29/00; A61P35/00; C07D417/14 | December 06, 2023 |
| US11834443B2 | Grant | Crystalline form of the compound (s)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diol | A61K31/047; A61K31/4245; A61K31/44; A61P37/00; C07D413/04; G01N23/20075 | December 05, 2023 |
| WO2023227721A1 | Application | Crystalline forms of sodium (5-(4-BROMOPHENYL)-6-(2-((5-BROMOPYRIMIDIN-2-YL)oxy)ethoxy)pyrimidin-4-yl)(SULFAMOYL)amide | A61P9/12; C07D239/47 | November 30, 2023 |
| WO2023227490A1 | Application | Aprocitentan for the treatment of hypertension | A61K31/41; A61K31/4422; A61K31/513; A61K31/549; A61K45/06; A61P9/12 | November 30, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer